Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2026-01-07 @ 11:32 PM
Study NCT ID:
NCT03297502
Status:
COMPLETED
Last Update Posted:
2017-09-29
First Post:
2017-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis
Sponsor:
Par Pharmaceutical, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-22
First Submit QC Date:
None
Study First Post Date:
2017-09-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-09-28
Last Update Post Date:
2017-09-29
Last Update Post Date Type:
ACTUAL